MyHealthChecked Valuation

Q: What is the Fair Price of MHC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

MHC (£0.13) is trading above our estimate of [[fair value]] (£0.08)

Is MHC undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of MHC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: MHC (£0.13) is trading above our estimate of fair value (£0.08)

Significantly Below Fair Value: MHC is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for MHC?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for MHC. This is calculated by dividing MHC's market cap by their current preferred multiple.
What is MHC's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	n/a

MHC key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.05x
Enterprise Value/EBITDA	-0.4x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does MHC's PS Ratio compare to its peers?

The above table shows the PS ratio for MHC vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	2.3x
RUA RUA Life Sciences	3.3x	32.2%	UK£7.1m
CNSL Cambridge Nutritional Sciences	0.8x	n/a	UK£7.6m
ABDX Abingdon Health	4.9x	30.7%	UK£29.9m
SPEC INSPECS Group	0.3x	5.5%	UK£62.0m
MHC MyHealthChecked	0.7x	n/a	UK£6.5m

Price-To-Sales vs Peers: MHC is good value based on its Price-To-Sales Ratio (0.7x) compared to the peer average (2.3x).

Price to Earnings Ratio vs Industry

How does MHC's PE Ratio compare vs other companies in the GB Medical Equipment Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	22.8%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	22.8%
	n/a	n/a	n/a

No more companies

Price-To-Sales vs Industry: MHC is good value based on its Price-To-Sales Ratio (0.7x) compared to the UK Medical Equipment industry average (2.9x).

Price to Sales Ratio vs Fair Ratio

What is MHC's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MHC PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	0.7x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate MHC's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.